Joint Formulary & PAD

Theophylline - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :
  • Modified release tablets
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Theophylline
Indication :
Asthma
Group Name :
Keywords :
respiratory, asthmatics, bronchodilators
Brand Names Include :
Uniphyllin continus, Slo-phyllin, Neulin SA
Important Information :
Place in therapy under review. Therapeutic drug monitoring required. Not recommended for primary care initiation without specialist advice.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Theophylline is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Asthma.

Committee Recommendations (1)

The place in therapy of theophylline MR is under review. The role of theophylline in the management of asthma and COPD has changed and become much more limited now that more effective, and safer treatments are available.  Therapeutic drug monitoring is required in patients on theophylline, which further limits its usefulness. Recent national guidance emphasises the need for organisations to ensure they have management systems in place to support the safe use of this medicine.  It is not recommended that GPs initiate theophylline in primary care without seeking specialist advice.